Findings

What do systematic reviews say?

8 questions · 8 findings · 1 reviews

No studies found 2 · 25%GRADE not reported 0 · 0%Very low 6 · 75%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Other liver‐related complications · cirrhotic participants with large ascites treated by paracentesis

It is very uncertain whether other plasma expanders changes other liver‐related complications compared with albumin (very low certainty).

1 finding from 1 review

Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis 2019 · Cochrane Headline outcomes only
RR 1.1 [0.82, 1.48]
16 studies · 1083 participants
Very low

Refractory ascites · cirrhotic participants with large ascites treated by paracentesis

The review found no eligible studies for this question.

1 finding from 1 review

Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Incidence of renal impairment · cirrhotic participants with large ascites treated by paracentesis

It is very uncertain whether other plasma expanders changes renal impairment compared with albumin (very low certainty).

1 finding from 1 review

Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis 2019 · Cochrane Headline outcomes only
RR 1.17 [0.71, 1.91]
17 studies · 1107 participants
Very low

Non‐serious adverse events · cirrhotic participants with large ascites treated by paracentesis

It is very uncertain whether other plasma expanders changes non‐serious adverse events compared with albumin (very low certainty).

1 finding from 1 review

Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis 2019 · Cochrane Headline outcomes only
RR 1.37 [0.66, 2.85]
14 studies · 977 participants
Very low

All‐cause mortality · cirrhotic participants with large ascites treated by paracentesis

It is very uncertain whether other plasma expanders changes all‐cause mortality compared with albumin (very low certainty).

1 finding from 1 review

Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis 2019 · Cochrane Headline outcomes only
RR 1.03 [0.82, 1.3]
14 studies · 1014 participants
Very low

Serious adverse events · cirrhotic participants with large ascites treated by paracentesis

It is very uncertain whether other plasma expanders changes serious adverse events compared with albumin (very low certainty).

1 finding from 1 review

Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis 2019 · Cochrane Headline outcomes only
RR 0.89 [0.1, 8.3]
2 studies · 118 participants
Very low

Health‐related quality of life · cirrhotic participants with large ascites treated by paracentesis

The review found no eligible studies for this question.

1 finding from 1 review

Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Other liver‐related complications · cirrhotic participants with large ascites treated by paracentesis

It is very uncertain whether plasma expanders changes other liver‐related complications compared with no plasma expanders (very low certainty).

1 finding from 1 review

Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis 2019 · Cochrane Headline outcomes only
RR 1.61 [0.79, 3.27]
4 studies · 248 participants
Very low